ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

HEPA Hepion Pharmaceuticals Inc

1.37
0.08 (6.20%)
2024年4月27日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Hepion Pharmaceuticals Inc HEPA NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.08 6.20% 1.37 09:00:00
始値 安値 高値 終値 前日終値
1.29 1.27 1.44 1.37 1.29
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2005:30GLOBEHepion Pharmaceuticals Initiates Wind-Down Activities in..
2024/2/1623:02EDGAR2Form 8-K - Current report
2024/2/1622:00GLOBEHepion Pharmaceuticals Announces Exercise of Warrants for..
2024/2/1505:38EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/1/0407:15GLOBEHepion Pharmaceuticals to Present at NASH-TAG 2024
2024/1/0406:30EDGAR2Form 8-K - Current report
2023/12/0722:00GLOBEHepion Pharmaceuticals Announces Restructuring Plan to..
2023/11/2906:15GLOBEHepion Pharmaceuticals to Present at the 7th Obesity & NASH..
2023/11/1406:05GLOBEHepion Pharmaceuticals Announces Major Reductions in Liver..
2023/11/1022:50GLOBEHepion Pharmaceuticals Schedules Conference Call to Review..
2023/11/0914:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/10/2521:30GLOBEHepion Pharmaceuticals’ Rencofilstat Demonstrates..
2023/9/2921:00GLOBEHepion Pharmaceuticals Announces $5.0 Million Registered..
2023/9/2205:05GLOBEHepion Pharmaceuticals to Participate in 2023 Cantor Global..
2023/9/2121:00GLOBENew Anti-Cancer Opportunities Revealed for Hepion..
2023/9/1922:00GLOBEHepion Pharmaceuticals Discovers Novel Rencofilstat Action..
2023/9/1821:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/1421:45GLOBERencofilstat Produces Positive Outcomes in Translational..
2023/9/0705:40EDGAR2Form 8-K - Current report
2023/9/0705:30GLOBEHepion Pharmaceuticals Announces Management Changes
2023/7/2505:04EDGAR2Form 8-K - Current report
2023/7/2205:41EDGAR2Form 8-K - Current report
2023/7/2205:39EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/6/1605:45GLOBEHepion Pharmaceuticals to Present Two Posters at EASL..
2023/6/1521:22GLOBEHepion Pharmaceuticals Announces Passing of Key Safety..
2023/5/2505:45GLOBEHepion Pharmaceuticals to Highlight AI-POWR™ at the 2023..
2023/5/2220:00GLOBEHepion Pharmaceuticals’ Phase 2 ‘ALTITUDE-NASH’ Trial..
2023/5/2005:05GLOBEHepion Pharmaceuticals Schedules Conference Call to Review..
2023/5/1100:15GLOBEHepion Pharmaceuticals, Inc. Announces Reverse Stock Split

最近閲覧した銘柄

Delayed Upgrade Clock